2C-C

Current official national law expressly controls 2C-C in United States; unauthorized possession, supply, or manufacture is prohibited.

2C-C is expressly listed by the current Criminal Code Regulations as both a controlled drug and a border controlled drug. The Criminal Code Act therefore supplies federal conduct-specific routes for possession and import/export, subject to the statutory elements and fault rules; listing alone is not an unqualified prohibition of every act. The current June 2026 Poisons Standard places alkoxyphenylethylamines and substituted alkoxyphenylethylamines in Schedule 9, whose prohibited-substance description includes approved research and analytical, teaching or training exceptions and whose implementation may vary among States and Territories. Customs Schedule 4 item 5B lists the alkoxyphenylethylamine class, and regulation 5 conditionally prohibits importation of a covered drug absent the required licence, permission, presentation, timing and quantity compliance, subject to its approval and medical exceptions. These Commonwealth provisions do not establish a blanket ban on all substituted phenethylamines or the entire 2C-X family.

RDC nº 6/2014 added 2C-C by name to Lista F2 of Portaria SVS/MS nº 344/1998.¹⁶ The current annex continues to list 2C-C as 4-chloro-2,5-dimethoxyphenethylamine in Lista F2, the list of psychotropic substances whose use is proscribed in Brazil. Under Lei nº 11.343/2006, substances on periodically updated federal executive lists are drugs, and drugs are prohibited throughout Brazil except where authorized by law or regulation. Unauthorized acquisition, possession, storage, transport, or carrying for personal consumption is subject to Article 28's warning, community-service, and educational measures; the broader unauthorized conduct enumerated in Article 33 is punishable by five to fifteen years' imprisonment and 500 to 1,500 day-fines.

Current official national law expressly controls 2C-C in Canada; unauthorized possession, supply, or manufacture is prohibited.

2C-C is expressly listed by exact chemical identity in China's current non-medical narcotic and psychotropic catalog. The catalog distinguishes it from the separate item 3, 2C-C-NBOMe (CAS 1227608-02-7). The current catalog was issued on 2025-07-21 and took effect on publication, replacing the prior supplemental catalog; the exact 2C-C entry was already in the 2015 supplemental catalog, whose measure took effect on 2015-10-01. Under current Regulation Article 4, a non-medical listed substance may be used for experimental research only as provided by the Regulation and may not be produced, operated/sold, used, stored, or transported. The 2015 implementing measure expressly prohibits any unit or individual from producing, buying/selling, transporting, using, storing, or importing/exporting listed non-medical substances, while preserving regulated handling for research, testing standards/reference materials, and specified intermediates. No personal-use quantity threshold or amount-based exception is stated in the applicable instruments. The current catalog note includes possible salts, stereoisomers, and their salts unless otherwise provided. Regulation Article 82 provides, where a violation causes a controlled narcotic or psychotropic substance to enter an illicit channel and cause harm, criminal liability where constitutive, or otherwise a RMB 50,000–100,000 police fine plus confiscation; serious cases may add a 2–5-times-illegal-proceeds fine and cancellation of the relevant license.

2C-C is covered by Annex 1 List B no. 460's generic Phenethylamin-gruppen because its 4-chloro-2,5-dimethoxyphenethylamine structure has the specified phenethylamine core with ring alkoxy and halogen substituents. The absence of a standalone 2C-C line does not preclude coverage under List B, which is subject to its medical/scientific-use limitation and the authorization and prescription exceptions in the current Danish regulation and section 2 of the governing statute.

Current official national law expressly controls 2C-C in Germany; unauthorized possession, supply, or manufacture is prohibited.

The consolidated ordinance text dated 17 June 2025 places 2C-C by exact chemical name and synonym in First Schedule Part A, Section B, item 3ג. The ordinance definition of dangerous drug covers substances in the First Schedule, their salts, and preparations, compounds, mixtures or solutions; Part A item 3ג is not the Part B medicinal-possession category described by section 11. Section 7(a) prohibits possession or use except as authorized by the Ordinance, regulations or a Director's licence; section 7(c) provides a general maximum of 20 years' imprisonment or 25 times the statutory fine, and a personal-consumption-only maximum of three years or the ordinary statutory fine. Section 6 applies the same 20-year/25-times maximum to unauthorized growing, production, extraction, preparation or manufacture. Section 13 prohibits unauthorized export, import, facilitating export/import, trade, other dealing or supply, and section 19A provides the same 20-year/25-times maximum for violations of that trade/import sign. These are statutory maxima and do not imply that every case receives the maximum. The 2025 official Reshumot notice amended the First Schedule's chemical-group definition and inserted other named substances; item 3ג remains in the current consolidated text. The current consolidated entry does not state a Gregorian month, and the UNODC intergovernmental Israel record reports known first control in 2007 under Notice 5767-2007; the exact historical notice and date remain unspecified.

2C-C is a designated substance: article 1, item 112 of Ministerial Ordinance No. 14 of 2007 covers 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine and its salts, and article 2 of the same ordinance defines the medical and other uses for which handling remains permitted. Manufacture, import, sale, transfer, possession, purchase, storage for sale or transfer, and display for purposes other than permitted medical or other uses are prohibited.¹⁵ The ordinance stands as amended by Ministerial Ordinance No. 103 of 17 June 2026, in force 27 June 2026, and Ministerial Ordinance No. 131 of 18 August 2026, in force 28 August 2026. The Ministry of Health, Labour and Welfare's list of designated substances as of 6 September 2026 lists 2C-C at entry 110 with an enforcement date of 1 April 2007.

The exact trivial name 2C-C is not printed as a separate named entry in the current Annex 2 text. 2C-C is structurally covered because it is 2-(4-chloro-2,5-dimethoxyphenyl)ethanamine, while List I II.11(1) expressly covers derivatives of 2-(2,5-dimethoxyphenyl)ethanamine bearing benzene-ring substituents. List I is the prohibited category; § 5 bans ordinary cultivation, production, manufacture, import/export, distribution, advertising, transport, storage, transfer, acquisition, use and transit. The 0.02 g and 2 g thresholds classify small and large quantities and do not create a personal-use exception. Section 7 authorizes specified medical/veterinary scientific research, physical/chemical property determination and training.

Classified as a health hazard since March 1, 2005 under regulation SFS 2005:26, pursuant to the Act on the Prohibition of Certain Goods Dangerous to Health (Lagen om förbud mot vissa hälsofarliga varor). The current consolidated Förordning (1999:58) continues to list 2C-C as a hälsofarlig vara. Under section 3 of Lag (1999:42), covered goods may not without authorization be transferred, offered for sale, or possessed; authorization may be granted for scientific or industrial handling.

The official Gazette decision expressly identifies 2C-C at annex item 47 with its chemical names and states that the listed substances are made subject to Law No. 2313 under Article 19. The 2025 Türkiye Uyuşturucu Raporu describes Turkey's NPS early-warning process and reports that 1,078 NPS had been brought within Law 2313 through 31 July 2025, including 143 phenethylamine-group substances. Decision No. 11418, published 13 June 2026, adds six other substances; its annex does not restate 2C-C and does not purport to repeal the 2013 entry. TCK Article 188(1) covers unlicensed or unauthorized manufacture, import or export; Article 188(3) covers domestic sale, offering, giving, dispatch, transport, storage, purchase, acceptance or possession; and Article 191(1) covers buying, accepting, possessing or using for personal use. The published penalty ranges do not specify a sentence for a particular 2C-C case. 2C-C's classification as a phenethylamine does not by itself establish that the Article 188(4)(a) half-increase for amphetamine and derivatives applies. The schedule decision does not describe medical, research, licensing, quantity or other exceptions; any authorization or exception depends on the operative Turkish legislation for the particular conduct. The official Gazette lists the exact name, and the current Law 2313 framework continues to apply; absence from a later additions list does not repeal the 2013 entry.

Controlled under the Misuse of Drugs Act 1971 via the phenethylamine catch-all clause.⁶⁵ The Home Office controlled-drugs list expressly identifies 4-chloro-2,5-dimethoxyphenethylamine (2C-C) as Class A under the Act. Subject to regulations under section 7 and the statutory defences, sections 4 and 5 make unauthorized production, supply and possession offences.

Conventional 2C-C is not an expressly named NPSV entry; in Austria, it is covered through the generic NPSV Annex II no. 2 phenethylamine class, with NPSV § 1(1)(2) treating Annex II-covered substances as NPS. Under the NPSG, § 4(1) establishes a conduct- and intent-specific offense for advantage-seeking production, import, export, transfer or supply intended for another person's or a third party's psychoactive use, punishable by up to two years' imprisonment. NPSG §§ 2 and 5 preserve lawful-marketing and lawful-purpose exceptions. The cited provisions do not categorically prohibit simple possession or personal use of 2C-C.

2C-C is expressly named in Finland's current consumer-market-banned psychoactive-substance annex, with the chemical identity 2-(2,5-dimethoxy-4-chlorophenyl)ethanamine. The annex lists the exact name, rather than relying on a generic analogue rule. The Narcotics Act definition expressly excludes medicinal substances and narcotics from this category, which is separate from narcotic scheduling. Section 5(2) bans manufacture, import, storage, offering for sale and transfer; it does not itself state a blanket possession-or-use prohibition. Exceptions include the research and justified industrial routes with prior notification, plus the low-misuse-risk mixture/preparation exception in section 23b. Criminal Code chapter 44 section 5a provides a fine or up to one year's imprisonment for intentional or grossly negligent violations, unless a more severe offence applies.

Specifically named as a controlled substance under Verzeichnis E of Swiss narcotics legislation.⁶²